BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36289998)

  • 1. The Safety and Efficacy of Phage Therapy: A Systematic Review of Clinical and Safety Trials.
    Stacey HJ; De Soir S; Jones JD
    Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Safety and Efficacy of Phage Therapy for Superficial Bacterial Infections: A Systematic Review.
    Steele A; Stacey HJ; de Soir S; Jones JD
    Antibiotics (Basel); 2020 Oct; 9(11):. PubMed ID: 33138253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Safety and Efficacy of Phage Therapy for Infections in Cardiac and Peripheral Vascular Surgery: A Systematic Review.
    Simpson EA; MacLeod CS; Stacey HJ; Nagy J; Jones JD
    Antibiotics (Basel); 2023 Nov; 12(12):. PubMed ID: 38136718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Safety and Efficacy of Phage Therapy for Bone and Joint Infections: A Systematic Review.
    Clarke AL; De Soir S; Jones JD
    Antibiotics (Basel); 2020 Nov; 9(11):. PubMed ID: 33182795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
    Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
    Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review.
    Uyttebroek S; Chen B; Onsea J; Ruythooren F; Debaveye Y; Devolder D; Spriet I; Depypere M; Wagemans J; Lavigne R; Pirnay JP; Merabishvili M; De Munter P; Peetermans WE; Dupont L; Van Gerven L; Metsemakers WJ
    Lancet Infect Dis; 2022 Aug; 22(8):e208-e220. PubMed ID: 35248167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can phage therapy solve the problem of recalcitrant chronic rhinosinusitis?
    Szaleniec J; Górski A; Szaleniec M; Międzybrodzki R; Weber-Dąbrowska B; Stręk P; Składzień J
    Future Microbiol; 2017 Nov; 12():1427-1442. PubMed ID: 29027819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the limitations on the wider therapeutic use of phage?
    Henein A
    Bacteriophage; 2013 Apr; 3(2):e24872. PubMed ID: 24228220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Fisher SA; Brunskill SJ; Doree C; Gooding S; Chowdhury O; Roberts DJ
    Cochrane Database Syst Rev; 2013 Aug; (8):CD004450. PubMed ID: 23963793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
    Woolacott N; Hawkins N; Mason A; Kainth A; Khadjesari Z; Vergel YB; Misso K; Light K; Chalmers R; Sculpher M; Riemsma R
    Health Technol Assess; 2006 Nov; 10(46):1-233, i-iv. PubMed ID: 17083854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
    Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
    Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of phage therapy via the intravenous route.
    Speck P; Smithyman A
    FEMS Microbiol Lett; 2016 Feb; 363(3):. PubMed ID: 26691737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophage Therapy: Advances in Formulation Strategies and Human Clinical Trials.
    Vandenheuvel D; Lavigne R; Brüssow H
    Annu Rev Virol; 2015 Nov; 2(1):599-618. PubMed ID: 26958930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal chemotherapy treatment for women with recurrent ovarian cancer.
    Fung-Kee-Fung M; Oliver T; Elit L; Oza A; Hirte HW; Bryson P
    Curr Oncol; 2007 Oct; 14(5):195-208. PubMed ID: 17938703
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.